uridine triphosphate has been researched along with charybdotoxin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (75.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, JW; Burnett, JE; Camden, JM; James-Kracke, MR; Kim, HD; Landon, LA; Turner, JT | 1 |
| Katusic, ZS; Kinoshita, H | 1 |
| Briner, V; Fischer, KG; Greger, R; Henger, A; Huber-Lang, M; Pavenstädt, H; Schollmeyer, P | 1 |
| Katusic, ZS; Onoue, H | 2 |
| Breittmayer, V; Husson, H; Lazdunski, M; Millet, MA; Moghrabi, B; Romey, G; Rossi, B; Schmid-Alliana, A; Schmid-Antomarchi, H; Ventura, MA | 1 |
| Lee, SP; Moody, MW; Nguyen, TD; Savard, CE | 1 |
| Fujii, F; Kimura, J; Tase, C | 1 |
| Bryan, RM; Johnson, TD; Marrelli, SP; Mombouli, JV; You, J | 1 |
| Hoffmann, EK | 1 |
| Ambudkar, IS; Liu, X; Singh, BB | 1 |
| Bergdahl, A; Edvinsson, L; Erlinge, D; Hedner, T; Malmsjö, M; Sun, XY; Zhao, XH | 1 |
| El-Mahmoudy, A; Matsuyama, H; Shimizu, Y; Takewaki, T; Thapaliya, S | 1 |
| Jang, SH; Lee, SY; Maniak, PJ; O'Grady, SM; Palmer, ML; Ryu, PD | 1 |
| Daut, J; Gao, YD; Hanley, PJ; Rinné, S; Zuzarte, M | 1 |
| Maniak, PJ; O'Grady, SM; Palmer, ML; Peitzman, ER; Prakash, YS; Sieck, GC | 1 |
16 other study(ies) available for uridine triphosphate and charybdotoxin
| Article | Year |
|---|---|
Potentiation of regulatory volume decrease by P2U purinoceptors in HSG-PA cells.
Topics: Biological Transport; Calcium; Cell Line; Charybdotoxin; Chlorides; Gramicidin; Humans; Hypotonic Solutions; Intracellular Membranes; Ions; Membrane Potentials; Osmolar Concentration; Potassium Channels; Receptors, Purinergic; Rubidium; Submandibular Gland; Uridine Triphosphate | 1996 |
Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis.
Topics: 4-Aminopyridine; Acidosis; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Barium Compounds; Basilar Artery; Calcium Channel Blockers; Charybdotoxin; Chlorides; Dogs; Endothelium, Vascular; Female; Glyburide; Hydrogen-Ion Concentration; Ion Channel Gating; KATP Channels; Male; Molsidomine; Muscle, Smooth, Vascular; Potassium Channels; Potassium Channels, Inwardly Rectifying; Uridine Triphosphate; Vasodilation | 1997 |
Agonist-induced activation of a non-selective ion current in glomerular endothelial cells.
Topics: Adenosine Triphosphate; Amiloride; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels; Cattle; Cells, Cultured; Charybdotoxin; Chlorine; Endothelium; Flufenamic Acid; Ion Channels; Ion Transport; Ionophores; Kidney Glomerulus; Membrane Potentials; Nicardipine; Patch-Clamp Techniques; Potassium; Sodium; Thionucleotides; Uridine Triphosphate | 1997 |
Subarachnoid hemorrhage and the role of potassium channels in relaxations of canine basilar artery to nitrovasodilators.
Topics: 4-Aminopyridine; Animals; Basilar Artery; Charybdotoxin; Cyclic GMP; Dogs; Female; Humans; Male; Molsidomine; Nitroprusside; Potassium Channels; Subarachnoid Hemorrhage; Uridine Triphosphate; Vasodilation; Vasodilator Agents | 1998 |
The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bradykinin; Cerebral Arteries; Charybdotoxin; Colforsin; Cyclic GMP; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Hydrazines; In Vitro Techniques; Isometric Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitrogen Oxides; Oxadiazoles; Quinoxalines; Uridine Triphosphate | 1998 |
Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel.
Topics: Adenosine Triphosphate; Antioxidants; Calcium; Cell Differentiation; Cells, Cultured; Charybdotoxin; Extracellular Space; Humans; Macrophages; Monocytes; Opsonin Proteins; Potassium Channel Blockers; Potassium Channels; Reactive Oxygen Species; Uridine Triphosphate; Zymosan | 1997 |
Secretory effects of ATP on nontransformed dog pancreatic duct epithelial cells.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Adenosine Triphosphate; Animals; Barium Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Charybdotoxin; Chlorides; Dogs; Epithelial Cells; Kinetics; Mucins; Nitrobenzoates; ortho-Aminobenzoates; Pancreatic Ducts; Potassium Channels; Rubidium Radioisotopes; Uridine Triphosphate | 1998 |
Ca(2+)-activated K+ current induced by external ATP in PC12 cells.
Topics: Adenosine Triphosphate; Animals; Apamin; Calcium; Charybdotoxin; Chelating Agents; Egtazic Acid; Membrane Potentials; Patch-Clamp Techniques; PC12 Cells; Peptides; Potassium Channels; Rats; Receptors, Purinergic P2; Solutions; Tetraethylammonium; Uridine Triphosphate | 1999 |
P2u receptor-mediated release of endothelium-derived relaxing factor/nitric oxide and endothelium-derived hyperpolarizing factor from cerebrovascular endothelium in rats.
Topics: 4-Aminopyridine; Animals; Apamin; Barium Compounds; Cerebral Arteries; Cerebrovascular Circulation; Charybdotoxin; Chlorides; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxadiazoles; Peptides; Potassium Channels; Potassium Chloride; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Tetraethylammonium; Uridine Triphosphate; Vasodilation | 1999 |
Leukotriene D4 (LTD4) activates charybdotoxin-sensitive and -insensitive K+ channels in ehrlich ascites tumor cells.
Topics: Adenosine Triphosphate; Animals; Bradykinin; Bumetanide; Calcium; Carcinoma, Ehrlich Tumor; Charybdotoxin; Female; Kinetics; Leukotriene Antagonists; Leukotriene D4; Membrane Proteins; Mice; Potassium; Potassium Channels; Propionates; Quinolines; Receptors, Leukotriene; Rubidium Radioisotopes; Uridine Triphosphate | 1999 |
ATP-dependent activation of K(Ca) and ROMK-type K(ATP) channels in human submandibular gland ductal cells.
Topics: Adenosine Triphosphate; Calcium; Cells, Cultured; Charybdotoxin; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Lanthanum; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Submandibular Gland; Thapsigargin; Tolbutamide; Uridine Triphosphate | 1999 |
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure.
Topics: Acetylcholine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Apamin; Biological Factors; Charybdotoxin; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Indomethacin; Linear Models; Male; Nitric Oxide Synthase; Nitroarginine; Nucleotides; Rats; Rats, Sprague-Dawley; Uridine Triphosphate; Vasodilator Agents | 1999 |
An endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Apamin; Biological Factors; Charybdotoxin; Cricetinae; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Glyburide; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Mesenteric Arteries; Mesocricetus; Muscle, Smooth, Vascular; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ouabain; Pinacidil; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Synaptic Transmission; Tetraethylammonium; Time Factors; Triazines; Uridine Triphosphate; Vasodilator Agents | 2003 |
P2Y receptor regulation of sodium transport in human mammary epithelial cells.
Topics: Adenosine Triphosphate; Amiloride; Biological Transport; Calcium; Cells, Cultured; Charybdotoxin; Chelating Agents; Clotrimazole; Cystic Fibrosis Transmembrane Conductance Regulator; Egtazic Acid; Epithelial Cells; Epithelial Sodium Channels; Humans; Hydrocortisone; Intermediate-Conductance Calcium-Activated Potassium Channels; Mammary Glands, Human; Membrane Potentials; Potassium Channel Blockers; Receptor, Adenosine A2B; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; RNA, Messenger; Sodium; Sodium Channel Blockers; Time Factors; Uridine Diphosphate; Uridine Triphosphate | 2007 |
Calcium-activated K(+) channel (K(Ca)3.1) activity during Ca(2+) store depletion and store-operated Ca(2+) entry in human macrophages.
Topics: Calcium; Calcium Channels; Calcium Signaling; Cell Adhesion Molecules; Charybdotoxin; Clotrimazole; HEK293 Cells; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; Macrophages; Membrane Proteins; Neoplasm Proteins; ORAI1 Protein; ORAI2 Protein; Patch-Clamp Techniques; Stromal Interaction Molecule 1; Stromal Interaction Molecule 2; Uridine Triphosphate | 2010 |
K(Ca)3.1 channels facilitate K+ secretion or Na+ absorption depending on apical or basolateral P2Y receptor stimulation.
Topics: Absorption; Adenosine Triphosphate; Apamin; Calcium; Cells, Cultured; Charybdotoxin; Clotrimazole; Egtazic Acid; Epithelial Cells; Humans; Ion Transport; Mammary Glands, Human; Membrane Potentials; Peptides; Potassium; Potassium Channels, Calcium-Activated; Purinergic Agonists; Pyrazoles; Receptors, Purinergic P2Y; Signal Transduction; Sodium; Uridine Triphosphate | 2011 |